ArticleJournal of imaging informatics in medicine2026
Deep Learning on Tumor Habitat Sub-regions vs. Whole-Tumor ROI: A Comparative Study of Fusion Strategies for Breast Cancer Molecular Subtype Prediction.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to compare deep learning models based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) whole-tumor and habitat regions of interest (ROIs) for non-invasive preoperative luminal subtype prediction in invasive breast cancer, and to evaluate three multi-modal fusion strategies in terms of discrimination, calibration, and clinical utility. In this multicenter, retrospective study, 396 patients with invasive breast cancer were included. A total of 276 patients from one center were divided into training (n = 220) and validation (n = 56) cohorts, with 120 patients from an independent institution serving as the external test set. Two-dimensional maximum cross-sectional images of whole-tumor ROI (group A) and habitat sub-region ROIs (group B) were extracted from DCE-MRI. ResNet50-based models were trained with four fixed random seeds, and three fusion approaches were compared: image-level early fusion, decision-level weighted fusion, and LR-Stacking fusion. In the external test set, group B achieved a numerically higher area under the curve (AUC) than group A (0.8187 vs. 0.7901), while the two models showed complementary strengths in calibration and threshold-dependent metrics. Among fusion models, decision-level weighted fusion achieved the highest AUC (0.8341), the best calibration (Brier score 0.1421), and the highest net clinical benefit across most threshold ranges on decision curve analysis. DeLong tests showed no significant pairwise AUC differences (all P > 0.05). Decision-level weighted fusion outperformed other fusion strategies across all three evaluation dimensions, supporting its potential as a practical tool for non-invasive preoperative luminal subtyping of breast cancer.
Indexed as
Identifiers
42315701What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.